Revenue and EBITDA grew in H1 2025, with strong margins and segment performance led by medical waste incineration. Investments in capacity and regulatory changes support future growth, while risk factors include receivable impairments and market price pressures.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.